QTREX Quantum Ltd. (QTEX)
QTEX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.58
0.00% on the day
Market cap
$88.4M
Micro cap
Revenue · 2025
$289K
Prior year not contiguous
Net income · 2025
-$13.2M
-4574.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | QTEX on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Israel |
| IPO year | 2021 |
| SEC CIK | 0001837493 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | L3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $289K |
| Net income | -$13.2M |
| Operating income | -$13.6M |
| Net margin | -4574.4% |
| Operating margin | -4713.8% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $3.2M |
| Total assets | $5.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 306.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2026-08-21 |
| Latest annual report FORM 20-F | 20-F | 2026-03-26 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-09 |
Source: SEC EDGAR submissions feed, 386 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PYPD | PolyPid Ltd. | $4.88 | -2.79% | $99.1M |
| LNSR | LENSAR Inc. | $6.27 | +0.80% | $77.0M |
| LUNG | Pulmonx Corporation | $1.76 | -2.22% | $75.6M |
| APYX | Apyx Medical Corporation | $2.60 | -1.89% | $109.5M |
| SKIN | SkinHealth Systems Inc. | $0.5406 | +2.97% | $70.4M |
| SKYA | SkyAI Inc. | $2.61 | +0.39% | $112.9M |
| MBOT | Microbot Medical Inc. | $1.02 | -1.92% | $68.5M |
| LUCD | Lucid Diagnostics Inc. | $0.6060 | +1.44% | $123.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier